Effect of pretreatment with transdermal testosterone on poor ovarian responders undergoing IVF/ICSI: A meta-analysis

Experimental and Therapeutic Medicine

Volumn 8, Issue 1, 2014, Pages 187-194

  Luo, Shan ^a   Li, Shang Wei ^a   Li, Xiao Hong ^a   Qin, Lang ^a   Jin, Song ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Androgens; In vitro fertilization; Poor ovarian responders; Randomized controlled trials; Testosterone

Indexed keywords

FOLLITROPIN; TESTOSTERONE;

ARTICLE; BIBLIOGRAPHIC DATABASE; BIRTH RATE; CLINICAL EVALUATION; DATA EXTRACTION; FEMALE; FERTILIZATION IN VITRO; GENETIC HETEROGENEITY; HUMAN; INFORMATION PROCESSING; INTRACYTOPLASMIC SPERM INJECTION; META ANALYSIS; OUTCOME ASSESSMENT; OVARY FUNCTION; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 84901322585     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1683     Document Type: Article

References (24)

1. Fasouliotis SJ, Simon A and Laufer N: Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet. J Assist Reprod Genet 17: 357-373, 2000.
2. Shanbhag S, Aucott L, Bhattacharya S, Hamilton MA and McTavish AR: Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilization (IVF). Cochrane Database Syst Rev 24: CD004379, 2007.
3. Kucuk T, Kozinoglu H and Kaba A: Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial. J Assist Reprod Genet 25: 123-127, 200.
4. Kyrou D, Kolibianakis EM, Venetis CA, Papanilolaou EG, Bontis J and Tarlatzis BC: How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systrmatic review and meta-analysis. Fertil Steril 91: 749-766, 2009.
5. Weil SJ, Vendola K, Zhou J, Adesanya OO, Wang J, Okafor J and Bondy CA: Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab 83: 2479-2485, 1998.
6. Vendola KA, Zhou J, Adesanya OO, Weil SJ and Bondy CA: Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 101: 2622-2629, 1998.
7. Vendola K, Zhou J, Wang J, Famuyiwa OA, Bievre M and Bondy CA: Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol Reprod 61: 353-357, 1999.
8. Garcia-Velasco JA, Moreno L, Pacheco A, Guillén A, Duque L, Requena A and Pellicer A: The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril 84: 82-87, 2005.
9. Higgins JPT and Green S (eds): Cochrane Handbook for Systematice Reviews of Interventions Version 5.1.0 (updated March 2011), The Cochrane Collaboration, 2011: www.handbook.cochrane.org
10. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D and Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354: 1896-1900,1999.
11. Sackett DL: Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 89 (2 Suppl): 2S-3S, 1986.
12. Higgins JP and Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558, 2002.
13. Balasch J, Fábregues F, Peñarrubia J, Carmona F, Casamitjana R, Creus M, Manau D, Casals G, and Vanrell JA: Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH. Hum Reprod 21: 1884-1893, 2006.
14. Massin N, Cedrin-Durnerin I, Coussieu C, Galey-Fontaine J, Wolf JP and Hugues JN: Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique - a prospective, randomized, double-blind study. Hum Reprod 21: 1204-1211, 2006.
15. Massin N, Cedrin-Durnerin I, Galey-Fontaine J, Coussieu C, Bry-Gauillard H and Hugues JN: Is androgen application beneficial for low responders. Hum Reprod 19 (Suppl 1): 120-121, 2004.
16. Feigenberg T, Simon A, Ben-Meir A, Gielchinsky Y and Laufer N: Role of androgens in the treatment of patients with low ovarian response. Reprod Biomed Online 19: 888-898, 2009.
17. Sunkara SK, Pundir J and Khalaf Y: Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis. Reprod Biomed Online 22: 545-555, 2011.
18. Gleicher N and Barad DH: Androgen priming before ovarian stimulation for IVF. Hum Reprod 23: 2868-2870, 2008.
19. Sipe CS and Van Voorhis BJ: Testosterone patch improves ovarian follicular response to gonadotrophins in a patient with Kallmann's syndrome: a case report. Hum Rerod 22: 1380-1383, 2007.
20. Sipe CS, Thomas MR, Stegmann BJ and Van Voorhis BJ: Effects of exogenous testosterone supplementation in gonadotrophin stimulated cycles. Hum Reprod 25: 690-696, 2010.
21. Kim CH, Howles CM and Lee HA: The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders. Fertil Steril 95: 679-683, 2011.
22. Fábregues F, Peñarrubia J, Creus M, Manau D, Casals G, Carmona F and Balasch J: Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial. Hum Reprod 24: 349-359, 2009
23. Barbieri RL, Sluss PM, Powers RD, McShane PM, Vitonis A, Ginsburg E and Cramer DC: Association of body mass index, age, and cigarette smoking with serum testosterone levels in cycling women undergoing in vitro fertilization. Fertil Steril 83: 302-308, 2005.
24. Fratarelli JL and Peterson EH: Effect of androgen levels on in vitro fertilization cycles. Fertil Steril 81: 1713-1714, 2004.